New preprint: evaluating a laboratory workflow for sequencing Mycobacteria using long-read sequencing Philip Fowler, 7th February 20269th April 2026 In this preprint, we describe and evaluate a laboratory workflow for sequencing Mycobacterial samples using long-read sequencing (as exemplified by Oxford Nanopore Technologies). A key part of this manuscript is the development of a lab protocol that combines rapid, semi-automated DNA extraction from MGIT cultures with PCR-based whole-genome amplification. Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related publication research tuberculosis
antimicrobial resistance New publication: Assessing Drug Susceptibility in Tuberculosis 28th September 201829th September 2018 A paper was published in the New England Journal of Medicine earlier this week by… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New paper: What can subpopulations tell us about rifampicin resistance? 14th October 202514th October 2025 Last Thursday this work which we’d previously preprinted looking at looking at rifampicin-resistant subpopulations in… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
This blog… 31st October 2012 …is where I shall put thoughts that at least might be of interest to other… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More